Apigenin manipulates the ubiquitin–proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit et al. · International Journal of Cancer · 2014 · 29K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Epoxomicin, a potent and selective proteasome inhibitor, exhibits <i>in vivo</i> antiinflammatory activity

Lihao Meng, Royce Mohan, Benjamin H. Kwok et al. · Proceedings of the National Academy of Sciences · 1999 · 933 citations

Life Sciences, Biochemistry, Molecular Biology +15

Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.

Kin‐Mang Lau, Mark LaSpina, John A. Long et al. · PubMed · 2000 · 357 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +15

United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma after One Prior Therapy

Robert C. Kane, Ann T. Farrell, Rajeshwari Sridhara et al. · Clinical Cancer Research · 2006 · 345 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome

Francesco Parlati, Monette Aujay, Érika Suzuki et al. · Blood · 2009 · 323 citations

Life Sciences, Biochemistry, Oncology +11